nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—Alitretinoin—hematologic cancer	0.215	1	CrCtD
Acitretin—Retinoids—Bexarotene—hematologic cancer	0.168	0.569	CiPCiCtD
Acitretin—Retinoids—Alitretinoin—hematologic cancer	0.127	0.431	CiPCiCtD
Acitretin—RARA—hematologic cancer	0.0953	0.903	CbGaD
Acitretin—Vitamin A—Alitretinoin—hematologic cancer	0.0456	0.333	CrCrCtD
Acitretin—Tretinoin—Alitretinoin—hematologic cancer	0.0456	0.333	CrCrCtD
Acitretin—Isotretinoin—Alitretinoin—hematologic cancer	0.0456	0.333	CrCrCtD
Acitretin—RXRG—Bexarotene—hematologic cancer	0.0272	0.165	CbGbCtD
Acitretin—RXRA—Bexarotene—hematologic cancer	0.024	0.146	CbGbCtD
Acitretin—RXRB—Bexarotene—hematologic cancer	0.024	0.146	CbGbCtD
Acitretin—RXRG—Alitretinoin—hematologic cancer	0.0156	0.0949	CbGbCtD
Acitretin—RARG—Alitretinoin—hematologic cancer	0.0156	0.0949	CbGbCtD
Acitretin—RXRB—Alitretinoin—hematologic cancer	0.0138	0.0839	CbGbCtD
Acitretin—RXRA—Alitretinoin—hematologic cancer	0.0138	0.0839	CbGbCtD
Acitretin—RARA—Alitretinoin—hematologic cancer	0.0138	0.0839	CbGbCtD
Acitretin—RARB—Alitretinoin—hematologic cancer	0.0138	0.0839	CbGbCtD
Acitretin—ALB—hematologic cancer	0.0103	0.0977	CbGaD
Acitretin—ALB—Imatinib—hematologic cancer	0.0011	0.00671	CbGbCtD
Acitretin—ALB—Prednisone—hematologic cancer	0.000728	0.00442	CbGbCtD
Acitretin—ALB—Irinotecan—hematologic cancer	0.00069	0.00419	CbGbCtD
Acitretin—RBP1—gonad—hematologic cancer	0.00045	0.0711	CbGeAlD
Acitretin—RARG—hematopoietic system—hematologic cancer	0.000446	0.0706	CbGeAlD
Acitretin—RARA—hematopoietic system—hematologic cancer	0.00042	0.0664	CbGeAlD
Acitretin—ALB—Methotrexate—hematologic cancer	0.000365	0.00222	CbGbCtD
Acitretin—RBP1—lung—hematologic cancer	0.000344	0.0543	CbGeAlD
Acitretin—RBP1—testis—hematologic cancer	0.000324	0.0513	CbGeAlD
Acitretin—RARA—gonad—hematologic cancer	0.000319	0.0505	CbGeAlD
Acitretin—RARB—lung—hematologic cancer	0.000318	0.0503	CbGeAlD
Acitretin—RARG—blood—hematologic cancer	0.000296	0.0468	CbGeAlD
Acitretin—RXRG—testis—hematologic cancer	0.000293	0.0464	CbGeAlD
Acitretin—RXRB—lung—hematologic cancer	0.000292	0.0462	CbGeAlD
Acitretin—RARA—blood—hematologic cancer	0.000278	0.044	CbGeAlD
Acitretin—RXRB—testis—hematologic cancer	0.000276	0.0436	CbGeAlD
Acitretin—Isotretinoin—RARA—hematologic cancer	0.000272	0.246	CrCbGaD
Acitretin—RARA—bone marrow—hematologic cancer	0.000269	0.0426	CbGeAlD
Acitretin—RARG—lung—hematologic cancer	0.000259	0.041	CbGeAlD
Acitretin—Alitretinoin—CRABP1—hematologic cancer	0.000253	0.229	CrCbGaD
Acitretin—RARG—testis—hematologic cancer	0.000245	0.0387	CbGeAlD
Acitretin—RARA—lung—hematologic cancer	0.000244	0.0386	CbGeAlD
Acitretin—RBP1—lymph node—hematologic cancer	0.000235	0.0372	CbGeAlD
Acitretin—RARA—testis—hematologic cancer	0.00023	0.0364	CbGeAlD
Acitretin—Alitretinoin—RARA—hematologic cancer	0.000221	0.201	CrCbGaD
Acitretin—RARB—lymph node—hematologic cancer	0.000217	0.0344	CbGeAlD
Acitretin—Tretinoin—CRABP1—hematologic cancer	0.000178	0.162	CrCbGaD
Acitretin—RARG—lymph node—hematologic cancer	0.000177	0.0281	CbGeAlD
Acitretin—RARA—lymph node—hematologic cancer	0.000167	0.0264	CbGeAlD
Acitretin—Tretinoin—RARA—hematologic cancer	0.000156	0.141	CrCbGaD
Acitretin—ALB—testis—hematologic cancer	0.00013	0.0205	CbGeAlD
Acitretin—ALB—lymph node—hematologic cancer	9.4e-05	0.0149	CbGeAlD
Acitretin—Alitretinoin—ABCB1—hematologic cancer	2.29e-05	0.0207	CrCbGaD
Acitretin—Haemoglobin—Doxorubicin—hematologic cancer	3.16e-06	6.41e-05	CcSEcCtD
Acitretin—Headache—Gemcitabine—hematologic cancer	3.16e-06	6.41e-05	CcSEcCtD
Acitretin—Nausea—Vincristine—hematologic cancer	3.16e-06	6.4e-05	CcSEcCtD
Acitretin—Flushing—Epirubicin—hematologic cancer	3.15e-06	6.39e-05	CcSEcCtD
Acitretin—Rhinitis—Doxorubicin—hematologic cancer	3.15e-06	6.39e-05	CcSEcCtD
Acitretin—Haemorrhage—Doxorubicin—hematologic cancer	3.14e-06	6.38e-05	CcSEcCtD
Acitretin—Hepatitis—Doxorubicin—hematologic cancer	3.14e-06	6.38e-05	CcSEcCtD
Acitretin—Hypersensitivity—Prednisolone—hematologic cancer	3.13e-06	6.35e-05	CcSEcCtD
Acitretin—Hypoaesthesia—Doxorubicin—hematologic cancer	3.13e-06	6.34e-05	CcSEcCtD
Acitretin—Pharyngitis—Doxorubicin—hematologic cancer	3.12e-06	6.33e-05	CcSEcCtD
Acitretin—Dyspepsia—Betamethasone—hematologic cancer	3.12e-06	6.33e-05	CcSEcCtD
Acitretin—Dyspepsia—Dexamethasone—hematologic cancer	3.12e-06	6.33e-05	CcSEcCtD
Acitretin—Urticaria—Triamcinolone—hematologic cancer	3.1e-06	6.29e-05	CcSEcCtD
Acitretin—Oedema peripheral—Doxorubicin—hematologic cancer	3.1e-06	6.28e-05	CcSEcCtD
Acitretin—Dysgeusia—Methotrexate—hematologic cancer	3.09e-06	6.28e-05	CcSEcCtD
Acitretin—Asthenia—Etoposide—hematologic cancer	3.09e-06	6.27e-05	CcSEcCtD
Acitretin—Body temperature increased—Triamcinolone—hematologic cancer	3.09e-06	6.26e-05	CcSEcCtD
Acitretin—Oedema—Prednisone—hematologic cancer	3.08e-06	6.26e-05	CcSEcCtD
Acitretin—Angiopathy—Epirubicin—hematologic cancer	3.08e-06	6.25e-05	CcSEcCtD
Acitretin—Decreased appetite—Betamethasone—hematologic cancer	3.08e-06	6.25e-05	CcSEcCtD
Acitretin—Decreased appetite—Dexamethasone—hematologic cancer	3.08e-06	6.25e-05	CcSEcCtD
Acitretin—Nausea—Irinotecan—hematologic cancer	3.07e-06	6.24e-05	CcSEcCtD
Acitretin—Nausea—Mitoxantrone—hematologic cancer	3.07e-06	6.24e-05	CcSEcCtD
Acitretin—Immune system disorder—Epirubicin—hematologic cancer	3.07e-06	6.22e-05	CcSEcCtD
Acitretin—Infection—Prednisone—hematologic cancer	3.06e-06	6.22e-05	CcSEcCtD
Acitretin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.06e-06	6.21e-05	CcSEcCtD
Acitretin—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.06e-06	6.21e-05	CcSEcCtD
Acitretin—Back pain—Methotrexate—hematologic cancer	3.06e-06	6.2e-05	CcSEcCtD
Acitretin—Fatigue—Betamethasone—hematologic cancer	3.05e-06	6.2e-05	CcSEcCtD
Acitretin—Fatigue—Dexamethasone—hematologic cancer	3.05e-06	6.2e-05	CcSEcCtD
Acitretin—Chills—Epirubicin—hematologic cancer	3.05e-06	6.18e-05	CcSEcCtD
Acitretin—Pruritus—Etoposide—hematologic cancer	3.05e-06	6.18e-05	CcSEcCtD
Acitretin—Pain—Betamethasone—hematologic cancer	3.03e-06	6.15e-05	CcSEcCtD
Acitretin—Pain—Dexamethasone—hematologic cancer	3.03e-06	6.15e-05	CcSEcCtD
Acitretin—Visual impairment—Doxorubicin—hematologic cancer	3.03e-06	6.14e-05	CcSEcCtD
Acitretin—Alopecia—Epirubicin—hematologic cancer	3e-06	6.09e-05	CcSEcCtD
Acitretin—Skin disorder—Prednisone—hematologic cancer	3e-06	6.08e-05	CcSEcCtD
Acitretin—Nausea—Gemcitabine—hematologic cancer	2.99e-06	6.07e-05	CcSEcCtD
Acitretin—Vomiting—Cisplatin—hematologic cancer	2.99e-06	6.06e-05	CcSEcCtD
Acitretin—Hyperhidrosis—Prednisone—hematologic cancer	2.98e-06	6.05e-05	CcSEcCtD
Acitretin—Vision blurred—Methotrexate—hematologic cancer	2.98e-06	6.04e-05	CcSEcCtD
Acitretin—Rash—Cisplatin—hematologic cancer	2.96e-06	6.01e-05	CcSEcCtD
Acitretin—Dermatitis—Cisplatin—hematologic cancer	2.96e-06	6.01e-05	CcSEcCtD
Acitretin—Erythema—Epirubicin—hematologic cancer	2.96e-06	6e-05	CcSEcCtD
Acitretin—Diarrhoea—Etoposide—hematologic cancer	2.95e-06	5.98e-05	CcSEcCtD
Acitretin—Anorexia—Prednisone—hematologic cancer	2.94e-06	5.97e-05	CcSEcCtD
Acitretin—Eye disorder—Doxorubicin—hematologic cancer	2.94e-06	5.96e-05	CcSEcCtD
Acitretin—Ill-defined disorder—Methotrexate—hematologic cancer	2.93e-06	5.95e-05	CcSEcCtD
Acitretin—Tinnitus—Doxorubicin—hematologic cancer	2.93e-06	5.94e-05	CcSEcCtD
Acitretin—Feeling abnormal—Dexamethasone—hematologic cancer	2.92e-06	5.92e-05	CcSEcCtD
Acitretin—Feeling abnormal—Betamethasone—hematologic cancer	2.92e-06	5.92e-05	CcSEcCtD
Acitretin—Flushing—Doxorubicin—hematologic cancer	2.92e-06	5.92e-05	CcSEcCtD
Acitretin—Tension—Epirubicin—hematologic cancer	2.9e-06	5.89e-05	CcSEcCtD
Acitretin—Gastrointestinal pain—Betamethasone—hematologic cancer	2.9e-06	5.88e-05	CcSEcCtD
Acitretin—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.9e-06	5.88e-05	CcSEcCtD
Acitretin—Dysgeusia—Epirubicin—hematologic cancer	2.9e-06	5.87e-05	CcSEcCtD
Acitretin—Hypersensitivity—Triamcinolone—hematologic cancer	2.88e-06	5.84e-05	CcSEcCtD
Acitretin—Nervousness—Epirubicin—hematologic cancer	2.87e-06	5.83e-05	CcSEcCtD
Acitretin—Back pain—Epirubicin—hematologic cancer	2.86e-06	5.8e-05	CcSEcCtD
Acitretin—Angiopathy—Doxorubicin—hematologic cancer	2.85e-06	5.78e-05	CcSEcCtD
Acitretin—Malaise—Methotrexate—hematologic cancer	2.85e-06	5.78e-05	CcSEcCtD
Acitretin—Dizziness—Etoposide—hematologic cancer	2.85e-06	5.78e-05	CcSEcCtD
Acitretin—Muscle spasms—Epirubicin—hematologic cancer	2.84e-06	5.77e-05	CcSEcCtD
Acitretin—Immune system disorder—Doxorubicin—hematologic cancer	2.84e-06	5.76e-05	CcSEcCtD
Acitretin—Chills—Doxorubicin—hematologic cancer	2.82e-06	5.72e-05	CcSEcCtD
Acitretin—Urticaria—Dexamethasone—hematologic cancer	2.81e-06	5.71e-05	CcSEcCtD
Acitretin—Urticaria—Betamethasone—hematologic cancer	2.81e-06	5.71e-05	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.81e-06	5.7e-05	CcSEcCtD
Acitretin—Dizziness—Prednisolone—hematologic cancer	2.81e-06	5.7e-05	CcSEcCtD
Acitretin—Asthenia—Triamcinolone—hematologic cancer	2.8e-06	5.68e-05	CcSEcCtD
Acitretin—Body temperature increased—Dexamethasone—hematologic cancer	2.8e-06	5.68e-05	CcSEcCtD
Acitretin—Abdominal pain—Dexamethasone—hematologic cancer	2.8e-06	5.68e-05	CcSEcCtD
Acitretin—Abdominal pain—Betamethasone—hematologic cancer	2.8e-06	5.68e-05	CcSEcCtD
Acitretin—Body temperature increased—Betamethasone—hematologic cancer	2.8e-06	5.68e-05	CcSEcCtD
Acitretin—Nausea—Cisplatin—hematologic cancer	2.79e-06	5.66e-05	CcSEcCtD
Acitretin—Insomnia—Prednisone—hematologic cancer	2.79e-06	5.66e-05	CcSEcCtD
Acitretin—Vision blurred—Epirubicin—hematologic cancer	2.79e-06	5.65e-05	CcSEcCtD
Acitretin—Alopecia—Doxorubicin—hematologic cancer	2.78e-06	5.63e-05	CcSEcCtD
Acitretin—Paraesthesia—Prednisone—hematologic cancer	2.77e-06	5.62e-05	CcSEcCtD
Acitretin—Pruritus—Triamcinolone—hematologic cancer	2.76e-06	5.6e-05	CcSEcCtD
Acitretin—Cough—Methotrexate—hematologic cancer	2.76e-06	5.59e-05	CcSEcCtD
Acitretin—Ill-defined disorder—Epirubicin—hematologic cancer	2.74e-06	5.57e-05	CcSEcCtD
Acitretin—Vomiting—Etoposide—hematologic cancer	2.74e-06	5.55e-05	CcSEcCtD
Acitretin—Erythema—Doxorubicin—hematologic cancer	2.74e-06	5.55e-05	CcSEcCtD
Acitretin—Dyspepsia—Prednisone—hematologic cancer	2.72e-06	5.51e-05	CcSEcCtD
Acitretin—Rash—Etoposide—hematologic cancer	2.71e-06	5.51e-05	CcSEcCtD
Acitretin—Dermatitis—Etoposide—hematologic cancer	2.71e-06	5.5e-05	CcSEcCtD
Acitretin—Headache—Etoposide—hematologic cancer	2.7e-06	5.47e-05	CcSEcCtD
Acitretin—Myalgia—Methotrexate—hematologic cancer	2.69e-06	5.46e-05	CcSEcCtD
Acitretin—Chest pain—Methotrexate—hematologic cancer	2.69e-06	5.46e-05	CcSEcCtD
Acitretin—Arthralgia—Methotrexate—hematologic cancer	2.69e-06	5.46e-05	CcSEcCtD
Acitretin—Tension—Doxorubicin—hematologic cancer	2.68e-06	5.45e-05	CcSEcCtD
Acitretin—Decreased appetite—Prednisone—hematologic cancer	2.68e-06	5.44e-05	CcSEcCtD
Acitretin—Dysgeusia—Doxorubicin—hematologic cancer	2.68e-06	5.44e-05	CcSEcCtD
Acitretin—Rash—Prednisolone—hematologic cancer	2.68e-06	5.43e-05	CcSEcCtD
Acitretin—Dermatitis—Prednisolone—hematologic cancer	2.67e-06	5.43e-05	CcSEcCtD
Acitretin—Malaise—Epirubicin—hematologic cancer	2.67e-06	5.41e-05	CcSEcCtD
Acitretin—Fatigue—Prednisone—hematologic cancer	2.66e-06	5.4e-05	CcSEcCtD
Acitretin—Headache—Prednisolone—hematologic cancer	2.66e-06	5.4e-05	CcSEcCtD
Acitretin—Discomfort—Methotrexate—hematologic cancer	2.66e-06	5.39e-05	CcSEcCtD
Acitretin—Nervousness—Doxorubicin—hematologic cancer	2.66e-06	5.39e-05	CcSEcCtD
Acitretin—Back pain—Doxorubicin—hematologic cancer	2.65e-06	5.37e-05	CcSEcCtD
Acitretin—Constipation—Prednisone—hematologic cancer	2.64e-06	5.35e-05	CcSEcCtD
Acitretin—Muscle spasms—Doxorubicin—hematologic cancer	2.63e-06	5.34e-05	CcSEcCtD
Acitretin—Dizziness—Triamcinolone—hematologic cancer	2.58e-06	5.24e-05	CcSEcCtD
Acitretin—Cough—Epirubicin—hematologic cancer	2.58e-06	5.23e-05	CcSEcCtD
Acitretin—Vision blurred—Doxorubicin—hematologic cancer	2.58e-06	5.23e-05	CcSEcCtD
Acitretin—Infection—Methotrexate—hematologic cancer	2.56e-06	5.2e-05	CcSEcCtD
Acitretin—Nausea—Etoposide—hematologic cancer	2.56e-06	5.19e-05	CcSEcCtD
Acitretin—Feeling abnormal—Prednisone—hematologic cancer	2.54e-06	5.16e-05	CcSEcCtD
Acitretin—Asthenia—Dexamethasone—hematologic cancer	2.54e-06	5.16e-05	CcSEcCtD
Acitretin—Asthenia—Betamethasone—hematologic cancer	2.54e-06	5.16e-05	CcSEcCtD
Acitretin—Ill-defined disorder—Doxorubicin—hematologic cancer	2.54e-06	5.15e-05	CcSEcCtD
Acitretin—Gastrointestinal pain—Prednisone—hematologic cancer	2.52e-06	5.12e-05	CcSEcCtD
Acitretin—Nausea—Prednisolone—hematologic cancer	2.52e-06	5.12e-05	CcSEcCtD
Acitretin—Chest pain—Epirubicin—hematologic cancer	2.52e-06	5.11e-05	CcSEcCtD
Acitretin—Myalgia—Epirubicin—hematologic cancer	2.52e-06	5.11e-05	CcSEcCtD
Acitretin—Arthralgia—Epirubicin—hematologic cancer	2.52e-06	5.11e-05	CcSEcCtD
Acitretin—Anxiety—Epirubicin—hematologic cancer	2.51e-06	5.09e-05	CcSEcCtD
Acitretin—Pruritus—Dexamethasone—hematologic cancer	2.51e-06	5.09e-05	CcSEcCtD
Acitretin—Pruritus—Betamethasone—hematologic cancer	2.51e-06	5.09e-05	CcSEcCtD
Acitretin—Skin disorder—Methotrexate—hematologic cancer	2.5e-06	5.08e-05	CcSEcCtD
Acitretin—Hyperhidrosis—Methotrexate—hematologic cancer	2.49e-06	5.06e-05	CcSEcCtD
Acitretin—Discomfort—Epirubicin—hematologic cancer	2.49e-06	5.05e-05	CcSEcCtD
Acitretin—Vomiting—Triamcinolone—hematologic cancer	2.48e-06	5.04e-05	CcSEcCtD
Acitretin—Malaise—Doxorubicin—hematologic cancer	2.47e-06	5.01e-05	CcSEcCtD
Acitretin—Rash—Triamcinolone—hematologic cancer	2.46e-06	4.99e-05	CcSEcCtD
Acitretin—Dry mouth—Epirubicin—hematologic cancer	2.46e-06	4.99e-05	CcSEcCtD
Acitretin—Dermatitis—Triamcinolone—hematologic cancer	2.46e-06	4.99e-05	CcSEcCtD
Acitretin—Anorexia—Methotrexate—hematologic cancer	2.46e-06	4.99e-05	CcSEcCtD
Acitretin—Urticaria—Prednisone—hematologic cancer	2.45e-06	4.97e-05	CcSEcCtD
Acitretin—Headache—Triamcinolone—hematologic cancer	2.45e-06	4.96e-05	CcSEcCtD
Acitretin—Body temperature increased—Prednisone—hematologic cancer	2.44e-06	4.95e-05	CcSEcCtD
Acitretin—Abdominal pain—Prednisone—hematologic cancer	2.44e-06	4.95e-05	CcSEcCtD
Acitretin—Diarrhoea—Dexamethasone—hematologic cancer	2.42e-06	4.92e-05	CcSEcCtD
Acitretin—Diarrhoea—Betamethasone—hematologic cancer	2.42e-06	4.92e-05	CcSEcCtD
Acitretin—Oedema—Epirubicin—hematologic cancer	2.41e-06	4.9e-05	CcSEcCtD
Acitretin—Infection—Epirubicin—hematologic cancer	2.4e-06	4.86e-05	CcSEcCtD
Acitretin—Cough—Doxorubicin—hematologic cancer	2.39e-06	4.84e-05	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.35e-06	4.77e-05	CcSEcCtD
Acitretin—Skin disorder—Epirubicin—hematologic cancer	2.34e-06	4.76e-05	CcSEcCtD
Acitretin—Dizziness—Betamethasone—hematologic cancer	2.34e-06	4.75e-05	CcSEcCtD
Acitretin—Dizziness—Dexamethasone—hematologic cancer	2.34e-06	4.75e-05	CcSEcCtD
Acitretin—Hyperhidrosis—Epirubicin—hematologic cancer	2.33e-06	4.73e-05	CcSEcCtD
Acitretin—Insomnia—Methotrexate—hematologic cancer	2.33e-06	4.73e-05	CcSEcCtD
Acitretin—Chest pain—Doxorubicin—hematologic cancer	2.33e-06	4.73e-05	CcSEcCtD
Acitretin—Arthralgia—Doxorubicin—hematologic cancer	2.33e-06	4.73e-05	CcSEcCtD
Acitretin—Myalgia—Doxorubicin—hematologic cancer	2.33e-06	4.73e-05	CcSEcCtD
Acitretin—Anxiety—Doxorubicin—hematologic cancer	2.32e-06	4.71e-05	CcSEcCtD
Acitretin—Nausea—Triamcinolone—hematologic cancer	2.32e-06	4.71e-05	CcSEcCtD
Acitretin—Paraesthesia—Methotrexate—hematologic cancer	2.32e-06	4.7e-05	CcSEcCtD
Acitretin—Discomfort—Doxorubicin—hematologic cancer	2.3e-06	4.67e-05	CcSEcCtD
Acitretin—Anorexia—Epirubicin—hematologic cancer	2.3e-06	4.67e-05	CcSEcCtD
Acitretin—Somnolence—Methotrexate—hematologic cancer	2.29e-06	4.65e-05	CcSEcCtD
Acitretin—Dry mouth—Doxorubicin—hematologic cancer	2.28e-06	4.62e-05	CcSEcCtD
Acitretin—Hypersensitivity—Prednisone—hematologic cancer	2.27e-06	4.61e-05	CcSEcCtD
Acitretin—Dyspepsia—Methotrexate—hematologic cancer	2.27e-06	4.6e-05	CcSEcCtD
Acitretin—Vomiting—Dexamethasone—hematologic cancer	2.25e-06	4.57e-05	CcSEcCtD
Acitretin—Vomiting—Betamethasone—hematologic cancer	2.25e-06	4.57e-05	CcSEcCtD
Acitretin—Decreased appetite—Methotrexate—hematologic cancer	2.24e-06	4.55e-05	CcSEcCtD
Acitretin—Rash—Betamethasone—hematologic cancer	2.23e-06	4.53e-05	CcSEcCtD
Acitretin—Rash—Dexamethasone—hematologic cancer	2.23e-06	4.53e-05	CcSEcCtD
Acitretin—Oedema—Doxorubicin—hematologic cancer	2.23e-06	4.53e-05	CcSEcCtD
Acitretin—Dermatitis—Dexamethasone—hematologic cancer	2.23e-06	4.53e-05	CcSEcCtD
Acitretin—Dermatitis—Betamethasone—hematologic cancer	2.23e-06	4.53e-05	CcSEcCtD
Acitretin—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.23e-06	4.52e-05	CcSEcCtD
Acitretin—Fatigue—Methotrexate—hematologic cancer	2.22e-06	4.51e-05	CcSEcCtD
Acitretin—Headache—Dexamethasone—hematologic cancer	2.22e-06	4.5e-05	CcSEcCtD
Acitretin—Headache—Betamethasone—hematologic cancer	2.22e-06	4.5e-05	CcSEcCtD
Acitretin—Infection—Doxorubicin—hematologic cancer	2.22e-06	4.5e-05	CcSEcCtD
Acitretin—Asthenia—Prednisone—hematologic cancer	2.21e-06	4.49e-05	CcSEcCtD
Acitretin—Pain—Methotrexate—hematologic cancer	2.2e-06	4.47e-05	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.2e-06	4.46e-05	CcSEcCtD
Acitretin—Pruritus—Prednisone—hematologic cancer	2.18e-06	4.43e-05	CcSEcCtD
Acitretin—Insomnia—Epirubicin—hematologic cancer	2.18e-06	4.43e-05	CcSEcCtD
Acitretin—Skin disorder—Doxorubicin—hematologic cancer	2.17e-06	4.4e-05	CcSEcCtD
Acitretin—Paraesthesia—Epirubicin—hematologic cancer	2.17e-06	4.4e-05	CcSEcCtD
Acitretin—Hyperhidrosis—Doxorubicin—hematologic cancer	2.16e-06	4.38e-05	CcSEcCtD
Acitretin—Somnolence—Epirubicin—hematologic cancer	2.14e-06	4.35e-05	CcSEcCtD
Acitretin—Anorexia—Doxorubicin—hematologic cancer	2.13e-06	4.32e-05	CcSEcCtD
Acitretin—Feeling abnormal—Methotrexate—hematologic cancer	2.12e-06	4.31e-05	CcSEcCtD
Acitretin—Dyspepsia—Epirubicin—hematologic cancer	2.12e-06	4.31e-05	CcSEcCtD
Acitretin—Diarrhoea—Prednisone—hematologic cancer	2.11e-06	4.28e-05	CcSEcCtD
Acitretin—Gastrointestinal pain—Methotrexate—hematologic cancer	2.11e-06	4.28e-05	CcSEcCtD
Acitretin—Nausea—Dexamethasone—hematologic cancer	2.1e-06	4.27e-05	CcSEcCtD
Acitretin—Nausea—Betamethasone—hematologic cancer	2.1e-06	4.27e-05	CcSEcCtD
Acitretin—Decreased appetite—Epirubicin—hematologic cancer	2.1e-06	4.26e-05	CcSEcCtD
Acitretin—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.08e-06	4.23e-05	CcSEcCtD
Acitretin—Fatigue—Epirubicin—hematologic cancer	2.08e-06	4.22e-05	CcSEcCtD
Acitretin—Constipation—Epirubicin—hematologic cancer	2.06e-06	4.19e-05	CcSEcCtD
Acitretin—Pain—Epirubicin—hematologic cancer	2.06e-06	4.19e-05	CcSEcCtD
Acitretin—Urticaria—Methotrexate—hematologic cancer	2.05e-06	4.16e-05	CcSEcCtD
Acitretin—Dizziness—Prednisone—hematologic cancer	2.04e-06	4.14e-05	CcSEcCtD
Acitretin—Abdominal pain—Methotrexate—hematologic cancer	2.04e-06	4.14e-05	CcSEcCtD
Acitretin—Body temperature increased—Methotrexate—hematologic cancer	2.04e-06	4.14e-05	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.03e-06	4.13e-05	CcSEcCtD
Acitretin—Insomnia—Doxorubicin—hematologic cancer	2.02e-06	4.1e-05	CcSEcCtD
Acitretin—Paraesthesia—Doxorubicin—hematologic cancer	2e-06	4.07e-05	CcSEcCtD
Acitretin—Feeling abnormal—Epirubicin—hematologic cancer	1.99e-06	4.03e-05	CcSEcCtD
Acitretin—Somnolence—Doxorubicin—hematologic cancer	1.98e-06	4.03e-05	CcSEcCtD
Acitretin—Gastrointestinal pain—Epirubicin—hematologic cancer	1.97e-06	4e-05	CcSEcCtD
Acitretin—Dyspepsia—Doxorubicin—hematologic cancer	1.97e-06	3.99e-05	CcSEcCtD
Acitretin—Vomiting—Prednisone—hematologic cancer	1.96e-06	3.98e-05	CcSEcCtD
Acitretin—RXRB—Gene Expression—CREBBP—hematologic cancer	1.95e-06	7.18e-05	CbGpPWpGaD
Acitretin—RARA—Gene Expression—CREBBP—hematologic cancer	1.95e-06	7.18e-05	CbGpPWpGaD
Acitretin—Rash—Prednisone—hematologic cancer	1.95e-06	3.95e-05	CcSEcCtD
Acitretin—RXRA—Gene Expression—HDAC2—hematologic cancer	1.94e-06	7.17e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ADCY7—hematologic cancer	1.94e-06	7.17e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—NCOA3—hematologic cancer	1.94e-06	7.17e-05	CbGpPWpGaD
Acitretin—Dermatitis—Prednisone—hematologic cancer	1.94e-06	3.94e-05	CcSEcCtD
Acitretin—Decreased appetite—Doxorubicin—hematologic cancer	1.94e-06	3.94e-05	CcSEcCtD
Acitretin—ALB—Platelet activation, signaling and aggregation—FN1—hematologic cancer	1.94e-06	7.16e-05	CbGpPWpGaD
Acitretin—Headache—Prednisone—hematologic cancer	1.93e-06	3.92e-05	CcSEcCtD
Acitretin—ALB—Metabolism—HDC—hematologic cancer	1.93e-06	7.12e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—NUP214—hematologic cancer	1.93e-06	7.12e-05	CbGpPWpGaD
Acitretin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.93e-06	3.91e-05	CcSEcCtD
Acitretin—Fatigue—Doxorubicin—hematologic cancer	1.92e-06	3.91e-05	CcSEcCtD
Acitretin—Urticaria—Epirubicin—hematologic cancer	1.92e-06	3.89e-05	CcSEcCtD
Acitretin—ALB—Hemostasis—LCK—hematologic cancer	1.92e-06	7.07e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.91e-06	7.05e-05	CbGpPWpGaD
Acitretin—Constipation—Doxorubicin—hematologic cancer	1.91e-06	3.87e-05	CcSEcCtD
Acitretin—Pain—Doxorubicin—hematologic cancer	1.91e-06	3.87e-05	CcSEcCtD
Acitretin—Abdominal pain—Epirubicin—hematologic cancer	1.91e-06	3.87e-05	CcSEcCtD
Acitretin—Body temperature increased—Epirubicin—hematologic cancer	1.91e-06	3.87e-05	CcSEcCtD
Acitretin—CYP26A1—Metabolism—PIK3R1—hematologic cancer	1.9e-06	7.02e-05	CbGpPWpGaD
Acitretin—Hypersensitivity—Methotrexate—hematologic cancer	1.9e-06	3.85e-05	CcSEcCtD
Acitretin—RBP1—Disease—MAPK3—hematologic cancer	1.9e-06	7e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—JAK2—hematologic cancer	1.9e-06	6.99e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.89e-06	6.98e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MAP2K1—hematologic cancer	1.89e-06	6.98e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—MTR—hematologic cancer	1.89e-06	6.98e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ABCG2—hematologic cancer	1.89e-06	6.98e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.88e-06	6.94e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—H3F3A—hematologic cancer	1.88e-06	6.93e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—GATA3—hematologic cancer	1.86e-06	6.86e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CG—hematologic cancer	1.86e-06	6.85e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ENO2—hematologic cancer	1.85e-06	6.84e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HSPA5—hematologic cancer	1.85e-06	6.83e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MDM2—hematologic cancer	1.85e-06	6.83e-05	CbGpPWpGaD
Acitretin—Asthenia—Methotrexate—hematologic cancer	1.85e-06	3.75e-05	CcSEcCtD
Acitretin—RBP1—Disease—MYC—hematologic cancer	1.85e-06	6.81e-05	CbGpPWpGaD
Acitretin—RBP1—Disease—TGFB1—hematologic cancer	1.84e-06	6.8e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.84e-06	6.79e-05	CbGpPWpGaD
Acitretin—Feeling abnormal—Doxorubicin—hematologic cancer	1.84e-06	3.73e-05	CcSEcCtD
Acitretin—Nausea—Prednisone—hematologic cancer	1.83e-06	3.72e-05	CcSEcCtD
Acitretin—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.83e-06	3.7e-05	CcSEcCtD
Acitretin—ALB—Hemostasis—PRKCZ—hematologic cancer	1.82e-06	6.73e-05	CbGpPWpGaD
Acitretin—Pruritus—Methotrexate—hematologic cancer	1.82e-06	3.7e-05	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—MTOR—hematologic cancer	1.8e-06	6.64e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CB—hematologic cancer	1.8e-06	6.64e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.8e-06	6.64e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—FGF2—hematologic cancer	1.8e-06	6.64e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTT1—hematologic cancer	1.8e-06	6.64e-05	CbGpPWpGaD
Acitretin—Hypersensitivity—Epirubicin—hematologic cancer	1.78e-06	3.61e-05	CcSEcCtD
Acitretin—Urticaria—Doxorubicin—hematologic cancer	1.77e-06	3.6e-05	CcSEcCtD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.77e-06	6.53e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CDA—hematologic cancer	1.77e-06	6.52e-05	CbGpPWpGaD
Acitretin—Body temperature increased—Doxorubicin—hematologic cancer	1.76e-06	3.58e-05	CcSEcCtD
Acitretin—Abdominal pain—Doxorubicin—hematologic cancer	1.76e-06	3.58e-05	CcSEcCtD
Acitretin—Diarrhoea—Methotrexate—hematologic cancer	1.76e-06	3.58e-05	CcSEcCtD
Acitretin—RXRA—Metabolism—SDC1—hematologic cancer	1.76e-06	6.49e-05	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CB—hematologic cancer	1.76e-06	6.48e-05	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.75e-06	6.44e-05	CbGpPWpGaD
Acitretin—Asthenia—Epirubicin—hematologic cancer	1.73e-06	3.51e-05	CcSEcCtD
Acitretin—RXRA—Developmental Biology—JAK2—hematologic cancer	1.73e-06	6.37e-05	CbGpPWpGaD
Acitretin—Pruritus—Epirubicin—hematologic cancer	1.71e-06	3.46e-05	CcSEcCtD
Acitretin—RBP1—Disease—KRAS—hematologic cancer	1.71e-06	6.29e-05	CbGpPWpGaD
Acitretin—Dizziness—Methotrexate—hematologic cancer	1.7e-06	3.46e-05	CcSEcCtD
Acitretin—ALB—Hemostasis—HDAC2—hematologic cancer	1.7e-06	6.27e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PC—hematologic cancer	1.7e-06	6.27e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CDKN1B—hematologic cancer	1.69e-06	6.23e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—AR—hematologic cancer	1.69e-06	6.22e-05	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.68e-06	6.21e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—CD44—hematologic cancer	1.68e-06	6.2e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—ITGA4—hematologic cancer	1.68e-06	6.2e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.68e-06	6.2e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.66e-06	6.12e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CASP3—hematologic cancer	1.66e-06	6.11e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL2—hematologic cancer	1.65e-06	6.1e-05	CbGpPWpGaD
Acitretin—Diarrhoea—Epirubicin—hematologic cancer	1.65e-06	3.35e-05	CcSEcCtD
Acitretin—Hypersensitivity—Doxorubicin—hematologic cancer	1.64e-06	3.34e-05	CcSEcCtD
Acitretin—ALB—Metabolism—GBA—hematologic cancer	1.64e-06	6.06e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC35B2—hematologic cancer	1.64e-06	6.06e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.64e-06	6.06e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IL3—hematologic cancer	1.64e-06	6.05e-05	CbGpPWpGaD
Acitretin—Vomiting—Methotrexate—hematologic cancer	1.64e-06	3.33e-05	CcSEcCtD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CD—hematologic cancer	1.63e-06	6.02e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IFNA1—hematologic cancer	1.63e-06	6.01e-05	CbGpPWpGaD
Acitretin—Rash—Methotrexate—hematologic cancer	1.63e-06	3.3e-05	CcSEcCtD
Acitretin—Dermatitis—Methotrexate—hematologic cancer	1.62e-06	3.3e-05	CcSEcCtD
Acitretin—Headache—Methotrexate—hematologic cancer	1.62e-06	3.28e-05	CcSEcCtD
Acitretin—ALB—Hemostasis—PTPN1—hematologic cancer	1.61e-06	5.95e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CCND1—hematologic cancer	1.61e-06	5.95e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—JUN—hematologic cancer	1.61e-06	5.94e-05	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—IL6—hematologic cancer	1.6e-06	5.92e-05	CbGpPWpGaD
Acitretin—Asthenia—Doxorubicin—hematologic cancer	1.6e-06	3.25e-05	CcSEcCtD
Acitretin—Dizziness—Epirubicin—hematologic cancer	1.6e-06	3.24e-05	CcSEcCtD
Acitretin—ALB—Hemostasis—RASGRP1—hematologic cancer	1.59e-06	5.85e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.59e-06	5.85e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SYK—hematologic cancer	1.58e-06	5.83e-05	CbGpPWpGaD
Acitretin—Pruritus—Doxorubicin—hematologic cancer	1.58e-06	3.2e-05	CcSEcCtD
Acitretin—RXRA—Transmembrane transport of small molecules—ALB—hematologic cancer	1.58e-06	5.82e-05	CbGpPWpGaD
Acitretin—RBP1—Disease—PIK3CA—hematologic cancer	1.57e-06	5.78e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CDKN1A—hematologic cancer	1.56e-06	5.75e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PTEN—hematologic cancer	1.56e-06	5.74e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—CDKN2B—hematologic cancer	1.55e-06	5.73e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3R1—hematologic cancer	1.54e-06	5.69e-05	CbGpPWpGaD
Acitretin—Vomiting—Epirubicin—hematologic cancer	1.53e-06	3.11e-05	CcSEcCtD
Acitretin—Nausea—Methotrexate—hematologic cancer	1.53e-06	3.11e-05	CcSEcCtD
Acitretin—Diarrhoea—Doxorubicin—hematologic cancer	1.53e-06	3.1e-05	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—MAPK8—hematologic cancer	1.52e-06	5.62e-05	CbGpPWpGaD
Acitretin—Rash—Epirubicin—hematologic cancer	1.52e-06	3.09e-05	CcSEcCtD
Acitretin—Dermatitis—Epirubicin—hematologic cancer	1.52e-06	3.08e-05	CcSEcCtD
Acitretin—CYP26A1—Metabolism—PTEN—hematologic cancer	1.52e-06	5.6e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IFNA2—hematologic cancer	1.52e-06	5.59e-05	CbGpPWpGaD
Acitretin—Headache—Epirubicin—hematologic cancer	1.51e-06	3.07e-05	CcSEcCtD
Acitretin—ALB—Metabolism—MTAP—hematologic cancer	1.5e-06	5.54e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—JAK2—hematologic cancer	1.5e-06	5.53e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CD44—hematologic cancer	1.49e-06	5.52e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—NQO1—hematologic cancer	1.49e-06	5.52e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EP300—hematologic cancer	1.48e-06	5.47e-05	CbGpPWpGaD
Acitretin—Dizziness—Doxorubicin—hematologic cancer	1.48e-06	3e-05	CcSEcCtD
Acitretin—RXRA—Gene Expression—NCOR1—hematologic cancer	1.47e-06	5.44e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.46e-06	5.4e-05	CbGpPWpGaD
Acitretin—RBP1—Disease—HRAS—hematologic cancer	1.45e-06	5.35e-05	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—EP300—hematologic cancer	1.45e-06	5.34e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SRC—hematologic cancer	1.44e-06	5.32e-05	CbGpPWpGaD
Acitretin—Nausea—Epirubicin—hematologic cancer	1.43e-06	2.91e-05	CcSEcCtD
Acitretin—ALB—Hemostasis—GRB2—hematologic cancer	1.43e-06	5.26e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PDGFA—hematologic cancer	1.42e-06	5.25e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CB—hematologic cancer	1.42e-06	5.25e-05	CbGpPWpGaD
Acitretin—Vomiting—Doxorubicin—hematologic cancer	1.42e-06	2.88e-05	CcSEcCtD
Acitretin—RXRA—Metabolism—CYCS—hematologic cancer	1.41e-06	5.22e-05	CbGpPWpGaD
Acitretin—Rash—Doxorubicin—hematologic cancer	1.41e-06	2.86e-05	CcSEcCtD
Acitretin—Dermatitis—Doxorubicin—hematologic cancer	1.41e-06	2.85e-05	CcSEcCtD
Acitretin—RXRA—Metabolism—HSP90AA1—hematologic cancer	1.41e-06	5.19e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—VEGFA—hematologic cancer	1.41e-06	5.19e-05	CbGpPWpGaD
Acitretin—Headache—Doxorubicin—hematologic cancer	1.4e-06	2.84e-05	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—STAT3—hematologic cancer	1.39e-06	5.13e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NRAS—hematologic cancer	1.39e-06	5.12e-05	CbGpPWpGaD
Acitretin—RBP1—Disease—IL6—hematologic cancer	1.39e-06	5.12e-05	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MAPK3—hematologic cancer	1.38e-06	5.1e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.38e-06	5.08e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—ABL1—hematologic cancer	1.37e-06	5.06e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—NR3C1—hematologic cancer	1.36e-06	5.03e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—EP300—hematologic cancer	1.35e-06	4.98e-05	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MYC—hematologic cancer	1.34e-06	4.96e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—FHL2—hematologic cancer	1.34e-06	4.94e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MAPK3—hematologic cancer	1.33e-06	4.91e-05	CbGpPWpGaD
Acitretin—Nausea—Doxorubicin—hematologic cancer	1.33e-06	2.69e-05	CcSEcCtD
Acitretin—RXRA—Developmental Biology—SRC—hematologic cancer	1.31e-06	4.85e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—AGRN—hematologic cancer	1.31e-06	4.84e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—IL2—hematologic cancer	1.31e-06	4.82e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MYC—hematologic cancer	1.29e-06	4.77e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TGFB1—hematologic cancer	1.29e-06	4.76e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HGF—hematologic cancer	1.29e-06	4.76e-05	CbGpPWpGaD
Acitretin—RBP1—Disease—AKT1—hematologic cancer	1.28e-06	4.72e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—VEGFA—hematologic cancer	1.28e-06	4.72e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—CSF2—hematologic cancer	1.27e-06	4.7e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—STAT3—hematologic cancer	1.27e-06	4.67e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.26e-06	4.67e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—NRAS—hematologic cancer	1.26e-06	4.66e-05	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MAPK3—hematologic cancer	1.26e-06	4.66e-05	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—MYC—hematologic cancer	1.25e-06	4.61e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTP1—hematologic cancer	1.25e-06	4.6e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—IDH2—hematologic cancer	1.24e-06	4.59e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—HMMR—hematologic cancer	1.24e-06	4.59e-05	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MAPK3—hematologic cancer	1.24e-06	4.57e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—JAK1—hematologic cancer	1.23e-06	4.54e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PRKCG—hematologic cancer	1.23e-06	4.54e-05	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MYC—hematologic cancer	1.23e-06	4.53e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MAPK3—hematologic cancer	1.21e-06	4.46e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.21e-06	4.45e-05	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MYC—hematologic cancer	1.2e-06	4.45e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KRAS—hematologic cancer	1.19e-06	4.41e-05	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MAPK3—hematologic cancer	1.19e-06	4.38e-05	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MAPK3—hematologic cancer	1.19e-06	4.38e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ABCB1—hematologic cancer	1.18e-06	4.35e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MAPK14—hematologic cancer	1.18e-06	4.35e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—TGFB1—hematologic cancer	1.17e-06	4.33e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.17e-06	4.33e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ARNTL—hematologic cancer	1.17e-06	4.32e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—ESR1—hematologic cancer	1.16e-06	4.27e-05	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MYC—hematologic cancer	1.15e-06	4.26e-05	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MYC—hematologic cancer	1.15e-06	4.26e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.15e-06	4.24e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IL2RA—hematologic cancer	1.15e-06	4.24e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTM1—hematologic cancer	1.15e-06	4.23e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—NCOR1—hematologic cancer	1.15e-06	4.23e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—SRC—hematologic cancer	1.14e-06	4.21e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CA9—hematologic cancer	1.14e-06	4.2e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ACP5—hematologic cancer	1.14e-06	4.2e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—NCOR2—hematologic cancer	1.12e-06	4.14e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—NOTCH1—hematologic cancer	1.12e-06	4.13e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	1.11e-06	4.1e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PDGFB—hematologic cancer	1.11e-06	4.09e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CA—hematologic cancer	1.1e-06	4.05e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—TNF—hematologic cancer	1.1e-06	4.05e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—KRAS—hematologic cancer	1.09e-06	4.01e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—CDK2—hematologic cancer	1.08e-06	3.97e-05	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CA—hematologic cancer	1.07e-06	3.95e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—IDH1—hematologic cancer	1.07e-06	3.95e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—hematologic cancer	1.06e-06	3.92e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—TXN—hematologic cancer	1.06e-06	3.9e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTO1—hematologic cancer	1.06e-06	3.9e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ABCC3—hematologic cancer	1.06e-06	3.9e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	1.05e-06	3.88e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SPHK1—hematologic cancer	1.04e-06	3.82e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—MAPK14—hematologic cancer	1.03e-06	3.81e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	1.02e-06	3.76e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—HRAS—hematologic cancer	1.02e-06	3.75e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—CREBBP—hematologic cancer	1.01e-06	3.74e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—MTHFR—hematologic cancer	1.01e-06	3.74e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—FN1—hematologic cancer	1e-06	3.69e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—UGT1A1—hematologic cancer	9.95e-07	3.67e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL6—hematologic cancer	9.72e-07	3.59e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC22A1—hematologic cancer	9.68e-07	3.57e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CRABP1—hematologic cancer	9.68e-07	3.57e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CG—hematologic cancer	9.57e-07	3.53e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ALOX5—hematologic cancer	9.43e-07	3.48e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PTPN11—hematologic cancer	9.4e-07	3.47e-05	CbGpPWpGaD
Acitretin—RARG—Gene Expression—AKT1—hematologic cancer	9.31e-07	3.44e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—HRAS—hematologic cancer	9.24e-07	3.41e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—NUP98—hematologic cancer	9.13e-07	3.37e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—AKT1—hematologic cancer	8.97e-07	3.31e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	8.92e-07	3.29e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—CREBBP—hematologic cancer	8.87e-07	3.27e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ADCY7—hematologic cancer	8.87e-07	3.27e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—NCOA3—hematologic cancer	8.87e-07	3.27e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—IL6—hematologic cancer	8.85e-07	3.26e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—NUP214—hematologic cancer	8.8e-07	3.25e-05	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—AKT1—hematologic cancer	8.74e-07	3.23e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	8.71e-07	3.21e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	8.67e-07	3.2e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ABCG2—hematologic cancer	8.62e-07	3.18e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—MTR—hematologic cancer	8.62e-07	3.18e-05	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—AKT1—hematologic cancer	8.52e-07	3.14e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CG—hematologic cancer	8.51e-07	3.14e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ENO2—hematologic cancer	8.46e-07	3.12e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CD—hematologic cancer	8.41e-07	3.1e-05	CbGpPWpGaD
Acitretin—RARB—Gene Expression—AKT1—hematologic cancer	8.35e-07	3.08e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTT1—hematologic cancer	8.2e-07	3.03e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—AKT1—hematologic cancer	8.16e-07	3.01e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.08e-07	2.98e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SDC1—hematologic cancer	8.02e-07	2.96e-05	CbGpPWpGaD
Acitretin—RARA—Gene Expression—AKT1—hematologic cancer	8.01e-07	2.96e-05	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—AKT1—hematologic cancer	8.01e-07	2.96e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3R1—hematologic cancer	7.94e-07	2.93e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CREBBP—hematologic cancer	7.89e-07	2.91e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—JAK2—hematologic cancer	7.72e-07	2.85e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	7.68e-07	2.83e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.66e-07	2.83e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CD—hematologic cancer	7.48e-07	2.76e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ALB—hematologic cancer	7.38e-07	2.72e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CB—hematologic cancer	7.33e-07	2.71e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.23e-07	2.67e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	7.08e-07	2.61e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3R1—hematologic cancer	7.06e-07	2.61e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—NQO1—hematologic cancer	6.82e-07	2.52e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CD44—hematologic cancer	6.82e-07	2.52e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IL2—hematologic cancer	6.73e-07	2.48e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.68e-07	2.46e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CB—hematologic cancer	6.52e-07	2.41e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYCS—hematologic cancer	6.45e-07	2.38e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—HSP90AA1—hematologic cancer	6.41e-07	2.37e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MAPK3—hematologic cancer	6.19e-07	2.28e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—EP300—hematologic cancer	6.04e-07	2.23e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MYC—hematologic cancer	6.02e-07	2.22e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SRC—hematologic cancer	5.88e-07	2.17e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.77e-07	2.13e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—VEGFA—hematologic cancer	5.72e-07	2.11e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTP1—hematologic cancer	5.69e-07	2.1e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—NRAS—hematologic cancer	5.65e-07	2.09e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTEN—hematologic cancer	5.63e-07	2.08e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.5e-07	2.03e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—MAPK3—hematologic cancer	5.41e-07	2e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ABCB1—hematologic cancer	5.38e-07	1.99e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—EP300—hematologic cancer	5.37e-07	1.98e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TGFB1—hematologic cancer	5.25e-07	1.94e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—NCOR1—hematologic cancer	5.22e-07	1.93e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTM1—hematologic cancer	5.22e-07	1.93e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—KRAS—hematologic cancer	4.87e-07	1.8e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—MTHFR—hematologic cancer	4.62e-07	1.7e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CA—hematologic cancer	4.47e-07	1.65e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—hematologic cancer	4.32e-07	1.6e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—AKT1—hematologic cancer	4.17e-07	1.54e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HRAS—hematologic cancer	4.14e-07	1.53e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.07e-07	1.5e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CA—hematologic cancer	3.97e-07	1.47e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CG—hematologic cancer	3.88e-07	1.43e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—AKT1—hematologic cancer	3.65e-07	1.35e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CREBBP—hematologic cancer	3.6e-07	1.33e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CD—hematologic cancer	3.41e-07	1.26e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—AKT1—hematologic cancer	3.25e-07	1.2e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3R1—hematologic cancer	3.22e-07	1.19e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CB—hematologic cancer	2.97e-07	1.1e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTEN—hematologic cancer	2.57e-07	9.48e-06	CbGpPWpGaD
Acitretin—ALB—Metabolism—EP300—hematologic cancer	2.45e-07	9.04e-06	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CA—hematologic cancer	1.81e-07	6.69e-06	CbGpPWpGaD
Acitretin—ALB—Metabolism—AKT1—hematologic cancer	1.48e-07	5.46e-06	CbGpPWpGaD
